Amrutanjan Health Care share news and announcements
NSE: AMRUTANJANBSE: 590006Pharmaceuticals & BiotechnologySmall Cap
Last close ₹487.65down ₹9.35 (1.88%)BSE ₹487.65
Share price at the NSE close on 23 Oct 2026. Previous close ₹497.00.
52-week range of traded prices to 23 Oct 2026
₹476.50Low, 16 Sep 2026₹760.15High, 29 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,410 Cr1,245th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 26.1
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 21.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 8 May 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.00%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 15.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 18.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 18.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 8 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 35,01263.2% delivered
Amrutanjan Health Care record dates, bonuses and splits
42 filed, newest first.
Aug 2026
11 Aug · Corporate action
Feb 2026
3 Feb · Corporate action
Nov 2025
10 Nov · Corporate action
Aug 2025
12 Aug · Corporate action
Feb 2025
12 Feb · Corporate action
Nov 2024
4 Nov · Corporate action
Aug 2024
14 Aug · Corporate action
Feb 2024
6 Feb · Corporate action
Nov 2023
10 Nov · Corporate action
Aug 2023
2 Aug · Corporate action
Jun 2023
30 Jun · Corporate action
Feb 2023
7 Feb · Corporate action
Oct 2022
27 Oct · Corporate action
Aug 2022
12 Aug · Corporate action
Feb 2022
7 Feb · Corporate action
Nov 2021
2 Nov · Corporate action
Aug 2021
14 Aug · Corporate action
Feb 2021
Nov 2020
5 Nov · Corporate action
Aug 2020
Feb 2020
Oct 2019
Feb 2019
Oct 2018
Aug 2018
Apr 2018
Feb 2018
Nov 2017
Feb 2017
Nov 2016
Mar 2016
Feb 2016
3 Feb · Corporate action
Company has fixed Record Date as February 19, 2016 for the purpose of Interim Dividend
Feb 2015
5 Feb · Corporate action
Company has fixed Record Date as February 17, 2015 for the purpose of interim Dividend.
Feb 2013
11 Feb · Corporate action
Company has fixed 22nd February 2013 as the Record Date for the purpose of payment of Interim Dividend of Re.1/- per share (50%) on the equity share capital for the financial year 2012-13. The Interim Dividend shall be paid on or after March 01, 2013. (Source MSE)
Aug 2012
6 Aug · Corporate action
Board of Directors, at its meeting held on 6th August 2012, had inter-alia, considered and approved the sub-division of existing equity share of nominal value of Rs. 10/- each fully up into two equity shares of nominal value of Rs. 5/- each fully paid up. (Source MSE)